This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.
This project is being performed to evaluate the outcomes of patients undergoing endoscopic procedures for upper gastrointestinal bleeding at all AdventHealth hospitals in Central Florida. This information will enable quality control of patients undergoing treatment for upper gastrointestinal bleeding across all campuses in the AdventHealth system in Central Florida and hence improve the delivery ot care extended to the investigator's patients.
Study Type
OBSERVATIONAL
Enrollment
2,999
Patients with upper gastrointestinal bleeding undergoing endoscopic therapy. Information regarding the need for interventional radiology procedures or surgical interventions will also be collected in patients in whom endoscopic therapy is not successful.
Center for Interventional Endoscopy
Orlando, Florida, United States
Mortality Rate
Mortality rate from upper gastrointestinal bleeding and from any etiology
Time frame: 30 days
Rate of Reintervention
Need for repeat endoscopic treatment for upper gastrointestinal bleeding
Time frame: 30 days
Rate of Recurrence
Recurrence of upper gastrointestinal bleeding following endoscopic treatment
Time frame: 30 days
Rate of Readmission
Need for readmission to hospital for treatment of upper gastrointestinal bleeding
Time frame: 30 days
Length of hospital stay
Length of hospitalization from index endoscopic procedure to discharge
Time frame: 30 days
Costs
Total hospital costs from admission for upper gastrointestinal bleeding
Time frame: 30 days
Treatment success
Successful treatment of upper gastrointestinal bleeding using endoscopic therapy as determined by a yes/no answer.
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.